Stock Events

Stock Events

Immunome 

$26.76
47
-$0.40-1.47% Friday 20:00
+$0.00+0%Friday 21:53After hours

Statistics

Day High
26.81
Day Low
26.73
52W High
30.06
52W Low
8.67
Volume
25,666
Avg. Volume
-
Mkt Cap
3.04B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.11
-0.9
-0.69
-0.48
Expected EPS
-0.6027
Actual EPS
N/A

Financials

-3,059.99%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
6.94MRevenue
-212.39MNet Income

Analyst Ratings

35.60Average Price Target
The highest estimate is 40.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IMNM. It's not an investment recommendation.
NVIDIA
15
NVDA
Microsoft
13
MSFT
Amazon
12
AMZN
Meta Platforms
12
META

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap55.09B
Moderna is a leader in mRNA technology, which can be used for developing vaccines and therapeutics, competing with Immunome's antibody discovery platform.
BioNTech
BNTX
Mkt Cap25.64B
BioNTech, similar to Moderna, focuses on mRNA technology for vaccines, directly competing in the infectious disease space with Immunome.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals develops monoclonal antibodies for the treatment of various diseases, directly competing with Immunome's antibody-based therapies.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences focuses on antiviral drugs for infections like HIV, hepatitis B, hepatitis C, and influenza, competing with Immunome's infectious disease focus.
AMGEN
AMGN
Mkt Cap233.78B
Amgen, a biotech giant, has a broad portfolio including immunotherapies and oncology, overlapping with Immunome's therapeutic areas.
Adaptive Biotechnologies
ADPT
Mkt Cap4.02B
Adaptive Biotechnologies works on the immune-driven medicine space, particularly in using the body's immune response to disease, competing with Immunome's approach to harnessing the immune system.
Novavax
NVAX
Mkt Cap1.53B
Novavax is focused on developing vaccines for infectious diseases, including COVID-19, competing in the same space as Immunome's infectious disease research.
Pfizer
PFE
Mkt Cap159.36B
Pfizer, with its broad range of vaccines and therapeutics, competes across several areas, including infectious diseases, where Immunome is also active.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its Janssen Pharmaceuticals division, develops treatments and vaccines for infectious diseases, competing with Immunome.
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Vertex Pharmaceuticals focuses on serious chronic diseases, including cystic fibrosis, where Immunome's novel antibody approaches could potentially compete.

About

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
Show more...
CEO
Clay Siegall
Employees
177
Country
United States
ISIN
US45257U1088

Listings

XNAS
US
IMNM
BOATS
BOATS
IMNM.BOATS

0 Comments

Share your thoughts

FAQ

What is Immunome stock price today?▼
The current price of IMNM is $26.76 USD — it has decreased by -1.47% in the past 24 hours. Watch Immunome stock price performance more closely on the chart.
What is Immunome stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Immunome stocks are traded under the ticker IMNM.
Is Immunome stock price growing?▼
IMNM stock has fallen by -2.94% compared to the previous week, the month change is a +4.86% rise, over the last year Immunome has showed a +154.37% increase.
What is Immunome market cap?▼
Today Immunome has the market capitalization of 3.04B
When is the next Immunome earnings date?▼
Immunome is going to release the next earnings report on November 16, 2026.
What were Immunome earnings last quarter?▼
IMNM earnings for the last quarter are -0.65 USD per share, whereas the estimation was -0.51 USD resulting in a -26.5% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Immunome revenue for the last year?▼
Immunome revenue for the last year amounts to 6.94M USD.
What is Immunome net income for the last year?▼
IMNM net income for the last year is -212.39M USD.
How many employees does Immunome have?▼
As of September 05, 2026, the company has 177 employees.
In which sector is Immunome located?▼
Immunome operates in the Health & Wellness sector.
When did Immunome complete a stock split?▼
The last stock split for Immunome was on December 19, 2007 with a ratio of 1:1000.
Where is Immunome headquartered?▼
Immunome is headquartered in BOTHELL, United States.